Paper28693158
Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.
Li Q and 3 others. Oncol Lett, 2017. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma. Papers, record 28693158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693158
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9351972 | Evidence for nucleotide excision repair as a modifying factor of O6-methylguanine-DNA methyltransferase-mediated innate chloroethylnitrosourea resistance in human tumor cell lines. | Mol Pharmacol | 1997 | https://conductscience.org/library/papers/9351972 | PubMed |
| 2 | 26423801 | Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology). | J Neurooncol | 2015 | https://conductscience.org/library/papers/26423801 | PubMed |
| 3 | 20668043 | Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression. | J Clin Endocrinol Metab | 2010 | https://conductscience.org/library/papers/20668043 | PubMed |
| 4 | 20428759 | Gene expression profiling predicts response to temozolomide in malignant gliomas. | Int J Oncol | 2010 | https://conductscience.org/library/papers/20428759 | PubMed |
| 5 | 20401838 | Efficacy of clinical prognostic factors on survival in patients with glioblastoma. | Turk Neurosurg | 2010 | https://conductscience.org/library/papers/20401838 | PubMed |
| 6 | 17332285 | Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17332285 | PubMed |
| 7 | 11070098 | Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. | N Engl J Med | 2000 | https://conductscience.org/library/papers/11070098 | PubMed |
| 8 | 20645919 | Reversal of multidrug resitance by natural substances from plants. | Curr Top Med Chem | 2010 | https://conductscience.org/library/papers/20645919 | PubMed |
| 9 | 14570288 | A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. | Neuropathology | 2003 | https://conductscience.org/library/papers/14570288 | PubMed |
| 10 | 17500046 | O6-methylguanine-DNA methyltransferase deficiency in developing brain: implications for brain tumorigenesis. | DNA Repair (Amst) | 2007 | https://conductscience.org/library/papers/17500046 | PubMed |
| 11 | 19846904 | p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. | Anticancer Res | 2009 | https://conductscience.org/library/papers/19846904 | PubMed |
| 12 | 25722935 | Immunotherapy for malignant glioma. | Surg Neurol Int | 2015 | https://conductscience.org/library/papers/25722935 | PubMed |
| 13 | 16476837 | Changing paradigms--an update on the multidisciplinary management of malignant glioma. | Oncologist | 2006 | https://conductscience.org/library/papers/16476837 | PubMed |
| 14 | 17482895 | MGMT hypermethylation: a prognostic foe, a predictive friend. | DNA Repair (Amst) | 2007 | https://conductscience.org/library/papers/17482895 | PubMed |
| 15 | 27531351 | Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients. | J Neurooncol | 2016 | https://conductscience.org/library/papers/27531351 | PubMed |
| 16 | 25599276 | Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection. | Neurosurg Focus | 2015 | https://conductscience.org/library/papers/25599276 | PubMed |
| 17 | 17827463 | Chemoradiotherapy in malignant glioma: standard of care and future directions. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17827463 | PubMed |
| 18 | 25910840 | The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide. | Neuro Oncol | 2015 | https://conductscience.org/library/papers/25910840 | PubMed |
| 19 | 17485253 | MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. | DNA Repair (Amst) | 2007 | https://conductscience.org/library/papers/17485253 | PubMed |
| 20 | 23282970 | Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma. | Am J Surg Pathol | 2013 | https://conductscience.org/library/papers/23282970 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40895460 | Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics. | Explor Target Antitumor Ther | 2025 | https://conductscience.org/library/papers/40895460 | PubMed |
| 38891074 | The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma. | Cells | 2024 | https://conductscience.org/library/papers/38891074 | PubMed |
| 37249862 | Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme. | Metab Brain Dis | 2023 | https://conductscience.org/library/papers/37249862 | PubMed |
| 34967558 | Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34967558 | PubMed |
| 34603316 | A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology. | Front Immunol | 2021 | https://conductscience.org/library/papers/34603316 | PubMed |
| 33801310 | Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33801310 | PubMed |
| 33671796 | Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. | Molecules | 2021 | https://conductscience.org/library/papers/33671796 | PubMed |
| 33394264 | A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care. | J Neurooncol | 2021 | https://conductscience.org/library/papers/33394264 | PubMed |
| 33282092 | Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment. | Pan Afr Med J | 2020 | https://conductscience.org/library/papers/33282092 | PubMed |
| 33001310 | MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33001310 | PubMed |
| 31323834 | DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions. | Biomolecules | 2019 | https://conductscience.org/library/papers/31323834 | PubMed |
| 30520434 | Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30520434 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MGMT | 4255 | PubTator's text mining | https://conductscience.org/library/genes/4255 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28693158
GET https://conductscience.org/api/papers/v1/28693158/references?page=2